Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Hans Hammers
Journal Article
5 A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREGTM) in Patients with Advanced or Metastatic Renal Cell Carcinoma, NCT06234605
The Oncologist, Volume 29, Issue Supplement_1, September 2024, Page S13, https://doi.org/10.1093/oncolo/oyae181.019
Published: 05 August 2024
Journal Article
The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023
The Oncologist, Volume 29, Issue 2, February 2024, Pages 91–98, https://doi.org/10.1093/oncolo/oyad322
Published: 04 December 2023
Journal Article
A Phase I Study of Alpha‐1,3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
The Oncologist, Volume 25, Issue 2, February 2020, Pages 121–e213, https://doi.org/10.1634/theoncologist.2019-0599
Published: 06 September 2019
Journal Article
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib
The Oncologist, Volume 21, Issue 10, October 2016, Pages 1212–1217, https://doi.org/10.1634/theoncologist.2015-0428
Published: 05 July 2016
Journal Article
Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
The Oncologist, Volume 19, Issue 1, January 2014, Pages 51–60, https://doi.org/10.1634/theoncologist.2012-0335
Published: 05 December 2013
Journal Article
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
The Oncologist, Volume 17, Issue 12, December 2012, Pages 1508–1514, https://doi.org/10.1634/theoncologist.2012-0125
Published: 12 September 2012
